Retrospective Study
Copyright ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 6, 2021; 9(19): 5064-5072
Published online Jul 6, 2021. doi: 10.12998/wjcc.v9.i19.5064
Microwave ablation combined with hepatectomy for treatment of neuroendocrine tumor liver metastases
Jin-Zhu Zhang, Shu Li, Wei-Hua Zhu, Da-Fang Zhang
Jin-Zhu Zhang, Shu Li, Wei-Hua Zhu, Da-Fang Zhang, Department of Hepatobiliary Surgery, Peking University People's Hospital, Beijing 100044, China
Author contributions: Zhang JZ designed the study, acquired and analyzed the data, and wrote the paper; Li S acquired and analyzed the data, and revised the paper; Zhu WH acquired and analyzed the data, and revised the paper; Zhang DF designed the study, revised the paper, and supervised the study.
Supported by Peking University People’s Hospital Scientific Research Development Funds, No. RDY2017-28.
Institutional review board statement: The study was reviewed and approved by the Peking University People’s Hospital Institutional Review Board (No. 2020PHB334-01).
Informed consent statement: Patients were not required to give informed consent to the stud because the analysis used anonymous clinical data that were obtained after each patient agreed to treatment by written consent.
Conflict-of-interest statement: All the authors have no conflict of interest related to the manuscript.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Da-Fang Zhang, MD, PhD, Associate Chief Physician, Associate Professor, Surgeon, Department of Hepatobiliary Surgery, Peking University People's Hospital, No. 11 South Street, West Straight Gate, Beijing 100044, China. zhangdafang03868@pkuph.edu.cn
Received: January 14, 2021
Peer-review started: January 14, 2021
First decision: April 4, 2021
Revised: April 13, 2021
Accepted: May 6, 2021
Article in press: May 6, 2021
Published online: July 6, 2021
Processing time: 161 Days and 2.9 Hours
Core Tip

Core Tip: Liver resection is the first choice for treating neuroendocrine tumor liver metastases. Due to the strict indications for hepatectomy, most patients with neuroendocrine tumor liver metastases are not suitable for hepatectomy. Ablation combined with hepatectomy is an alternative treatment option. Here, this study analyzed the clinical effect of microwave ablation combined with hepatectomy in the treatment of neuroendocrine tumor liver metastases. The results show that microwave ablation combined with hepatectomy not only makes the patients obtain a survival rate similar to that of patients undergoing hepatectomy, but also has a low incidence of postoperative complications.